Journal of Cardiac Failure
Volume 16, Issue 3 , Pages 225-229 , March 2010

COPD Predicts Mortality in HF: The Norwegian Heart Failure Registry

  • Jonathan De Blois, MD

      Affiliations

    • Centre Hospitalier Affilié Universitaire de Québec, Quebec, Canada
    • Corresponding Author InformationReprint requests: Jonathan De Blois, MD, FRCPC, Centre hospitalier affilié universitaire de Québec, Quebec, Canada. Tel: 418 649-0252.
    • ,
  • Serge Simard, MSC

      Affiliations

    • Quebec Heart and Lung Institute, Quebec, Canada
    • ,
  • Dan Atar, MD, PhD

      Affiliations

    • Oslo University Hospital Aker, Division of Cardiology, Faculty of Medicine, Oslo, Norway
    • ,
  • Stefan Agewall, MD, PhD

      Affiliations

    • Oslo University Hospital Aker, Division of Cardiology, Faculty of Medicine, Oslo, Norway
    • ,
  • For the Norwegian Heart Failure Registry

      Affiliations

    • The Norwegian Heart Failure Registry: Morten Grundtvig, Lars Gullestad, Arne Westheim, Torstein Hole

Received 23 July 2009 ,Revised 26 November 2009 ,Accepted 1 December 2009.

References 

  1. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med. 2000;343:269–280
  2. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007–2018
  3. Sidney S, Sorel M, Quesenberry CP, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128:2068–2075
  4. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127:1952–1959
  5. Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol. 2007;99:636–641
  6. Kjoller E, Kober L, Iversen K, Torp-Pedersen C. Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction. Eur J Heart Fail. 2004;6:71–77
  7. Dankner R, Goldbourt U, Boyko V, Reicher-Reiss H. Predictors of cardiac and noncardiac mortality among 14,697 patients with coronary heart disease. Am J Cardiol. 2003;91:121–127
  8. Hawkins NM, Huang Z, Pieper KS, Solomon SD, Kober L, Velazquez EJ, et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail. 2009;11:292–298
  9. Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42:1226–1233
  10. Macchia A, Monte S, Romero M, D'Ettorre A, Tognoni G. The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure. Eur J Heart Fail. 2007;9:942–948
  11. Rusinaru D, Saaidi I, Godard S, Mahjoub H, Battle C, Tribouilloy C. Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure. Am J Cardiol. 2008;101:353–358
  12. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555
  13. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115–1140
  14. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–367
  15. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed.. New York: John Wiley & Sons Inc; 2000;
  16. Gustafsson F, Torp-Pedersen C, Brendorp B, Seibaek M, Burchardt H, Kober L, et al. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur Heart J. 2003;24:863–870
  17. Staszewsky L, Wong M, Masson S, Barlera S, Carretta E, Maggioni AP, et al. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT Heart Failure Trial. J Cardiac Failure. 2007;13:797–804
  18. Olenchock BA, Fonarow GG, Pan W, Hernandez A, Cannon CP. Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes. Am J Cardiol. 2009;103:295–300
  19. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489–497
  20. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol. 2001;37:1950–1956
  21. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:e1–82
  22. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388–2442
  23. Mannino DM. Epidemiology and global impact of chronic obstructive pulmonary disease. Semin Respir Crit Care Med. 2005;26:204–210
  24. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359:2355–2365
  25. Agusti Ä, Soriano JB. COPD as a systemic disease. COPD: J Chronic Obstruct Pulmon Dis. 2008;5:133–138
  26. Sin DD, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107:1514–1519
  27. Polak JF, Holman BL, Wynne J, Colucci WS. Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J Am Coll Cardiol. 1983;2:217–224
  28. Vonk-Noordegraaf A, Marcus JT, Holverda S, Roseboom B, Postmus PE. Early changes of cardiac structure and function in COPD patients with mild hypoxemia. Chest. 2005;127:1898–1903
  29. Burgess MI, Mogulkoc N, Bright-Thomas RJ, Bishop P, Egan JJ, Ray SG. Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease. J Am Soc Echocardiogr. 2002;15:633–639
  30. Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J. 2003;21:892–905
  31. Girgis RE, Mathai SC. Pulmonary hypertension associated with chronic respiratory disease. Clin Chest Med. 2007;28:219–232
  32. Burger CD. Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators. COPD: J Chronic Obstruct Pulmon Dis. 2009;6:137–144
  33. Burrows B, Kettel LJ, Niden AH, Rabinowitz M, Diener CF. Patterns of cardiovascular dysfunction in chronic obstructive lung disease. N Engl J Med. 1972;286:912–918

 The authors have no conflicts to disclose.

PII: S1071-9164(09)01195-6

doi: 10.1016/j.cardfail.2009.12.002

Journal of Cardiac Failure
Volume 16, Issue 3 , Pages 225-229 , March 2010

Article Tools

* Image Usage & Resolution